Literature DB >> 15073423

Pulmonary function tests and thyroid hormone concentrations in patients with chronic obstructive pulmonary disease.

Oguzhan Okutan1, Zafer Kartaloglu, Mehmet Emin Onde, Erkan Bozkanat, Erdogan Kunter.   

Abstract

OBJECTIVE: To evaluate the relationship between pulmonary function tests, arterial blood gases, and thyroid gland functions in patients with chronic obstructive pulmonary disease (COPD). SUBJECTS AND METHODS: Thirty-two patients (mean age 64.1 +/- 7.3 years, range 53-84 years) with stable COPD (mean duration of disease 11.1 +/- 9.1 years, range 1-30 years) and 15 healthy control cases participated in the study. Pulmonary function, arterial blood gas, and thyroid hormone concentration were measured, and thyroid ultrasonography and scintigraphy were also performed.
RESULTS: The values of the pulmonary function tests (vital capacity, forced vital capacity, forced expiratory volume in 1 s and peak expiratory flow) and PaO2 were lower in the study than control group (p < 0.001), but the values of PaCO2 and concentration of free 3,5,3'-triiodothyronine (fT3) were higher in the study than control group (p < 0.01) although thyroid hormone concentrations were within normal limits in all cases. However, there was no difference between the values of thyroid-stimulating hormone and free thyroxine in both the study and control groups and therefore association could not be established between them on the one hand and pulmonary function test and arterial blood gases on the other hand. Only the values of PaCO2 and fT3 were positively associated; all other values were negatively associated with fT3.
CONCLUSION: Changes in pulmonary function tests and arterial blood gases seem to be associated with fT3 concentrations in patients with COPD. Increased respiratory workload could affect thyroid functions. Copyright 2004 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15073423     DOI: 10.1159/000076950

Source DB:  PubMed          Journal:  Med Princ Pract        ISSN: 1011-7571            Impact factor:   1.927


  6 in total

1.  Role of type 2 deiodinase in response to acute lung injury (ALI) in mice.

Authors:  Olga Barca-Mayo; Xiao-Hui Liao; Caterina DiCosmo; Alexandra Dumitrescu; Liliana Moreno-Vinasco; Michael S Wade; Saad Sammani; Tamara Mirzapoiazova; Joe G N Garcia; Samuel Refetoff; Roy E Weiss
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-07       Impact factor: 11.205

2.  Amiodarone-induced thyroid dysfunction: brand-name versus generic formulations.

Authors:  Meytal A Tsadok; Cynthia A Jackevicius; Elham Rahme; Vidal Essebag; Mark J Eisenberg; Karin H Humphries; Jack V Tu; Hassan Behlouli; Jennifer Joo; Louise Pilote
Journal:  CMAJ       Date:  2011-07-11       Impact factor: 8.262

3.  Type 2 deiodinase and host responses of sepsis and acute lung injury.

Authors:  Shwu-Fan Ma; Lishi Xie; Maria Pino-Yanes; Saad Sammani; Michael S Wade; Eleftheria Letsiou; Jessica Siegler; Ting Wang; Giovanni Infusino; Rick A Kittles; Carlos Flores; Tong Zhou; Bellur S Prabhakar; Liliana Moreno-Vinasco; Jesus Villar; Jeffrey R Jacobson; Steven M Dudek; Joe G N Garcia
Journal:  Am J Respir Cell Mol Biol       Date:  2011-06-17       Impact factor: 6.914

4.  COPD and thyroid dysfunctions.

Authors:  Claudio Terzano; S Romani; G Paone; V Conti; F Oriolo
Journal:  Lung       Date:  2013-11-27       Impact factor: 2.584

Review 5.  Underrecognized comorbidities of chronic obstructive pulmonary disease.

Authors:  Joanna Miłkowska-Dymanowska; Adam J Białas; Anna Zalewska-Janowska; Paweł Górski; Wojciech J Piotrowski
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-07-15

6.  Association of free thyroxine with obstructive lung pattern in euthyroid middle-aged subjects: A population-based study.

Authors:  Hye Jeong Kim; Sang Joon Park; Hyeong Kyu Park; Dong Won Byun; Kyoil Suh; Myung Hi Yoo
Journal:  PLoS One       Date:  2022-07-22       Impact factor: 3.752

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.